The top people in Boone County came together to talk about the community’s recent successes and future plans at their Annual ...

"I want to leave an impact on the Dover basketball program ... for all of the younger girls playing," Lilly Nossif says after setting scoring record.

Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

The boldest gesture was the funny but ambitious commercial that emphasized IndyCar’s excitement and showcased Josef Newgarden’s personality. Complete with a cameo of NFL legend Tom Brady ...

With its offering of tirzepatide (branded as Mounjaro and Zepbound), Eli Lilly and Co. (NYSE: LLY) was another key pharma player in this new type of treatment for diabetes and obesity.

FOX unveiled a new trailer ahead of the 2025 IndyCar season — which kicks off in St. Petersburg, Florida on March 2 — featuring three-time series champion Alex Palou. Beginning this season ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

Eli Lilly's Q4 FY24 guidance adjustment is due to supply chain factors, not demand, creating an attractive buying opportunity with a 'Buy' rating. Despite a modest 0.6% revenue reduction ...

Bank of America Securities analyst Tim Anderson maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares closed last Friday at $725.72. According to ...

In this article, we are going to take a look at where Eli Lilly And Co. (NYSE:LLY) stands against other stocks that could split in the near future. Stock splits don’t change how much a company ...